Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic factors determine extent of bone loss in inflammatory bowel disease.

Gastroenterology - 1 Oct 2000

Schulte C M, Dignass A U, Goebell H, Röher H D, Schulte K M

Abstract excerpt

BACKGROUND & AIMS: Although bone loss and osteoporosis are well-known long-term sequelae of inflammatory bowel disease (IBD), the risk factors for increased bone loss have not been identified. Balances of pro- and anti-inflammatory cytokines influence mechanisms of both chronic inflammation and bone resorption. The aim of this study was to identify genetic risk factors for rapid bone loss in IBD patients as a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Absorptiometry, Photon
Share to Alkaline Phosphatase
Share to Bone Resorption

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Collagen Type I

Share to HSP70 Heat-Shock Proteins

Share to Interleukin 1 Receptor Antagonist Protein

Share to Osteoporosis

Share to Sialoglycoproteins

Source

Identifiers

PMID: 11040178
DOI: 10.1053/gast.2000.18158

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic factors determine extent of bone loss in inflammatory bowel disease.PMID 11040178Read ↗

Allelic variation at the interleukin 1beta gene is associated with decreased bone mass in patients with inflammatory bowel diseases.Semantic proximity Read ↗

Genetic determinants of IL-6 expression levels do not influence bone loss in inflammatory bowel disease.Semantic proximity Read ↗

Genetics of bone loss in rheumatoid arthritis--role of vitamin D receptor polymorphisms.Semantic proximity Read ↗

Influence of IL-6, COL1A1, and VDR gene polymorphisms on bone mineral density in Crohn's disease.Semantic proximity Read ↗

Tumor necrosis factor-alpha haplotype is strongly associated with bone mineral density in patients with Crohn's disease.Semantic proximity Read ↗

Extraintestinal complications of inflammatory bowel disease.Semantic proximity Read ↗

Low body mass not vitamin D receptor polymorphisms predict osteoporosis in patients with inflammatory bowel disease.Semantic proximity Read ↗

Bone Metabolism and the c.-223C > T Polymorphism in the 5'UTR Region of the Osteoprotegerin Gene in Patients with Inflammatory Bowel Disease.Semantic proximity Read ↗

Absence of a genetic association between IL-1RN and IL-1B gene polymorphisms in ulcerative colitis and Crohn disease in multiple populations from northeast England.Semantic proximity Read ↗

Significant differences in the interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in a Hungarian population with inflammatory bowel disease.Semantic proximity Read ↗

ESR1 Gene Variants Are Predictive of Osteoporosis in Female Patients with Crohn’s DiseaseSemantic proximity Read ↗

Familial resemblance of bone mineral density in children with inflammatory bowel disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.